89bio Statistics
Total Valuation
89bio has a market cap or net worth of $741.94 million. The enterprise value is $350.45 million.
Important Dates
The next estimated earnings date is Thursday, February 27, 2025, after market close.
| Earnings Date | Feb 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
89bio has 117.58 million shares outstanding. The number of shares has increased by 50.52% in one year.
| Current Share Class | 117.58M |
| Shares Outstanding | 117.58M |
| Shares Change (YoY) | +50.52% |
| Shares Change (QoQ) | +7.26% |
| Owned by Insiders (%) | 0.70% |
| Owned by Institutions (%) | 57.05% |
| Float | 73.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.83 |
| P/TBV Ratio | 1.95 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.66, with a Debt / Equity ratio of 0.10.
| Current Ratio | 11.66 |
| Quick Ratio | 10.83 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -61.20 |
Financial Efficiency
Return on equity (ROE) is -73.31% and return on invested capital (ROIC) is -44.65%.
| Return on Equity (ROE) | -73.31% |
| Return on Assets (ROA) | -41.36% |
| Return on Capital (ROIC) | -44.65% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.13M |
| Employee Count | 70 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, 89bio has paid $4.30 million in taxes.
| Income Tax | 4.30M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.45% in the last 52 weeks. The beta is 1.05, so 89bio's price volatility has been similar to the market average.
| Beta (5Y) | 1.05 |
| 52-Week Price Change | -44.45% |
| 50-Day Moving Average | 8.34 |
| 200-Day Moving Average | 8.53 |
| Relative Strength Index (RSI) | 29.62 |
| Average Volume (20 Days) | 1,189,548 |
Short Selling Information
The latest short interest is 7.79 million, so 6.63% of the outstanding shares have been sold short.
| Short Interest | 7.79M |
| Short Previous Month | 6.94M |
| Short % of Shares Out | 6.63% |
| Short % of Float | 10.54% |
| Short Ratio (days to cover) | 6.70 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -303.86M |
| Pretax Income | -170.51M |
| Net Income | -288.96M |
| EBITDA | -303.81M |
| EBIT | -303.86M |
| Earnings Per Share (EPS) | -$3.01 |
Full Income StatementBalance Sheet
The company has $423.77 million in cash and $37.57 million in debt, giving a net cash position of $386.21 million or $3.28 per share.
| Cash & Cash Equivalents | 423.77M |
| Total Debt | 37.57M |
| Net Cash | 386.21M |
| Net Cash Per Share | $3.28 |
| Equity (Book Value) | 378.10M |
| Book Value Per Share | 3.56 |
| Working Capital | 417.08M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$280.54 million and capital expenditures -$4,000, giving a free cash flow of -$280.54 million.
| Operating Cash Flow | -280.54M |
| Capital Expenditures | -4,000 |
| Free Cash Flow | -280.54M |
| FCF Per Share | -$2.39 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |